CONCURRENT PROGRAMS

August 21-22

August 22-23

Enabling Point-of-Care Diagnostics 

Molecular Diagnostics
for Infectious Disease 

Emerging Molecular
Markers of Cancer 

Companion Diagnostics 

Mass Spectrometry in Clinical Diagnostics 

Commercialization of
Molecular Diagnostics 

Regulatory Compliance in Drug-Diagnostics Co-Development 

ABOUT THE SUMMIT

Technological advances in next generation diagnostics are driving growth and innovation in healthcare. Rapid and precise diagnosis is essential for personalized medicine and will change the way value is assessed and compensated in the healthcare system. This meeting offers a comprehensive view of the changing landscape of diagnostics and brings together the key players in the field.

The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Mass Spec for the Clinic) is designed to bring together all of the major players in the evolving areas of diagnostics. This year, we have assembled an impressive faculty of speakers from industry, government, and leading academic institutions. This meeting will showcase improvements in technology research and development with an emphasis on applications in the clinic and commercialization. Plan to hear what the industry leaders are saying about future market opportunities and network with your peers this August 21-23 in Washington, DC.